Skip to main content
. 2022 Apr 2;22:126. doi: 10.1186/s12883-022-02650-0

Table 3.

Mean change and 95% confidence interval and differences group-by-time interaction for secondary outcomes and questionnaires

Baseline – Final assessment
Intervention group (N = 17)
Baseline—Final assessment
Sham ultrasound group (N = 20)
Secondary outcomes Mean change (95% CI) p value Mean change (95% CI) p value Interaction group*time
Cervical range of motion Movement F; df; p value
Flexion -2.20 (-8.71; 4.30) 0.496 -7.93 (-14.95; -0.91) 0.028*CR 2.72; 34; 0.108
Extension -5.14 (-13.64; 3.36) 0.227 -6.69 (-15.94; 2.55) 0.151 0.12; 34; 0.728
Lateral flexion right -8.12 (-13.31; -2.93) 0.003*CR -5.84 (-11.48; -0.21) 0.042*CR 0.70; 34; 0.408
Lateral flexion left -5.61 (-12.13; 0.90) 0.089 -5.31 (-12.35; 1.71) 0.134 0.01; 34; 0.932
Rotation right -3.10 (-7.66; 1.46) 0.176CR -0.36 (-5.33; 4.61) 0.883CR 1.34; 34; 0.255
Rotation left -5.43 (-10.30; -0.57) 0.030*CR -7.01 (-12.36; -1.67) 0.012*CR 0.41; 34; 0.524
Pressure pain threshold Muscle
Frontal -0.37 (-0.77; 0.01) 0.058CR 0.04 (-0.39; 0.47) 0.860 4.30; 112; 0.040*
Anterior temporalis -0.46 (-0.80; -0.11) 0.009*.CR -0.23 (-0.61; 0.14) 0.219 1.65; 112; 0.201
Medium temporalis -0.42 (-0.87; 0.03) 0.067CR -0.06 (-0.55; 0.43) 0.808 2.43; 112; 0.122
Posterior temporalis -0.78 (-1.29; -0.27) 0.003*CR -0.29 (-0.84; 0.26) 0.305 3.64; 112; 0.059
Sternocleidomastoid -0.14 (-0.54; 0.26) 0.488 0.06 (-0.38; 0.50) 0.791 0.94; 112; 0.334
Scapular levator -0.22 (-0.78; 0.33) 0.422CR -0.10 (-0.71; 0.51) 0.749 0.20; 112; 0.657
Upper trapezius -0.26 (-0.42; -0.10) 0.002* CR -0.22 (-0.40; -0.04) 0.017* 0.28; 112; 0.595
Suboccipital -0.34 (-0.67; -0.02) 0.036* CR -0.18 (-0.54; 0.17) 0.305 0.95; 112; 0.331
CCFT Pressure stage
-0.95 (-2.40; 0.49) 0.192 -3.15 (-4.53; -1.77) 0.001* 2.60; 70; 0.081
MIVC Muscle group
Flexor
 Forcen (N/kg) 0.04 (-0.13; 0.20) 0.639 0.14 (-0.05; 0.31) 0.142 1.23; 34; 0.275
 Peak time (s) 2.80 (-0.58; 6.19) 0.102CR 2.73 (-0.88; 6.35) 0.134CR 0.00; 34; 0.971
Extensor
 Forcen (N/kg) -0.11 (-0.46; 0.24) 0.530CR 0.18 (-0.19; 0.57) 0.327 2.57; 34; 0.118
 Peak time (s) -4.65 (-8.42; -0.89) 0.017* -3.98 (-8.02; 0.05) 0.053 0.11; 34; 0.745
Endurance Muscle group
Flexor
 Endurance time (s) -9.64 (-29.64; 10.34) 0.334 -9.70 (-31.57; 12.16) 0.373 0.00; 34; 0.995
Extensor
 Endurance time (s) 65.15 (-33.98; 164.29) 0.190 51.87 (-54.82; 158.58) 0.330 0.07; 33; 0.796
Questionnaires Total score
MIDAS 13.64 (-11.03; 38.33) 0.269 3.16 (-23.40; 29.73) 0.810 0.62; 33; 0.436
NDI -2.22 (-6.47; 2.03) 0.292 -6.90 (-12.50; -1.29) 0.018* 3.90; 24; 0.059
ASC-12 1.20 (-1.64; 4.05) 0.396 -0.12 (-3.21; 2.97) 0.938 0.79; 34; 0.380
TAMPA -0.10 (-4.67; 4.46) 0.963 -1.83 (-6.87; 3.21) 0.465 0.58; 34; 0.452
PSFS -1.90 (-2.96; -0.84) 0.001* -1.77 (-2.93; -0.61) 0.003* 0.05; 173; 0.816

95% CI 95% confidence interval, CCFT craniocervical flexion test, MIVC maximal isometric voluntary contraction, Forcen force normalized by the subject mass, s seconds, MIDAS Migraine Disability Assessment NDI Neck Disability Index, ASC-12 12 item Allodynia Symptom Checklist, TAMPA Tampa Scale for Kinesiophobia, PSFS Patient-specific Functional Scale

*p < 0.05

CRclinically relevant